E
Emeraldpharma
emeraldpharma.com
Website unreachable since Oct 26, 2026
The startup develops synthetic cannabidiol and cannabigerol-based drug products for the treatment of inflammatory, autoimmune, and neurodegenerative diseases. By creating two families of new chemical entities, the company targets significant gaps in effective therapies for these conditions.
Traction –/10
San Diego, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops synthetic cannabidiol and cannabigerol-based drug products for the treatment of inflammatory, autoimmune, and neurodegenerative diseases. By creating two families of new chemical entities, the company targets significant gaps in effective therapies for these conditions.